Ophthalmic disease gene therapy - Belief Biomed
Latest Information Update: 12 Jan 2024
At a glance
- Originator Belief Biomed
- Class Eye disorder therapies; Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Eye disorders
Most Recent Events
- 24 Nov 2023 Preclinical trials in Eye disorders in China (Parenteral), prior to November 2023 (Belief Biomed pipeline, November 2023)